Medizinische Fakultät
Refine
Is part of the Bibliography
- yes (161)
Year of publication
Document Type
- Doctoral Thesis (107)
- Journal article (52)
- Preprint (1)
- Report (1)
Keywords
- Maus (5)
- Myc (4)
- Plasmozytom (4)
- Multiple Sklerose (3)
- Multiples Myelom (3)
- Schlaganfall (3)
- T-Lymphozyt (3)
- infection (3)
- microRNA (3)
- stroke (3)
- Adipositas (2)
- Anorexia nervosa (2)
- Antagonist (2)
- Apobec (2)
- COVID-19 (2)
- DNA (2)
- Depression (2)
- Entzündung (2)
- Expression (2)
- Fluoreszenz (2)
- Genetik (2)
- Handgelenk (2)
- Hemmstoff (2)
- Herzfrequenzvariabilität (2)
- Heubacillus (2)
- Mausmodell (2)
- Mitose (2)
- NSCLC (2)
- Neisseria meningitidis (2)
- Niereninsuffizienz (2)
- RN18 (2)
- RNA (2)
- ROS (2)
- Schmerz (2)
- Speckle tracking (2)
- Stress (2)
- TP53 (2)
- Thrombozyt (2)
- Translation <Genetik> (2)
- Vif (2)
- colorectal cancer (2)
- depression (2)
- diagnosis (2)
- echocardiography (2)
- electrocardiography (2)
- epidemiology (2)
- grip force (2)
- platelets (2)
- shRNA (2)
- strain rate (2)
- thrombo-inflammation (2)
- treatment (2)
- viability (2)
- 3-Ligament-Tenodese (1)
- 3D Mapping System (1)
- 3D mapping system (1)
- 3D-Kultur (1)
- 4-HNE (1)
- 5' UTR (1)
- ACC (1)
- ADHD (1)
- ADHS (1)
- AIDS (1)
- Abszission (1)
- Acceptance Evaluation (1)
- Adjuvans (1)
- Adrenocortical cancer (1)
- Adrenokortikales Karzinom (1)
- Advanced Glycation Endproducts (1)
- Advanced glycosylation end products (1)
- Affinity probe (1)
- Agonist (1)
- Aktivitätstest (1)
- Akzeptanz-Evaluation (1)
- Alternative Medizin (1)
- Alternativmedizin (1)
- Alzheimer`s disease (1)
- Alzheimerkrankheit (1)
- Angeborene Immunität (1)
- Angstsensitivität (1)
- Antigen CD4 (1)
- Antivirale Substanzen (1)
- Arthrodese (1)
- Arthroskopie (1)
- Aspergillus fumigatus (1)
- Atempumpe Sarkoidose (1)
- Aufwandsanalyse (1)
- Authoring Tools (1)
- Autoantikörper (1)
- Automatisierte Prüfungskorrektur (1)
- Autonome Balance (1)
- Autorensystem (1)
- BOLD signal (1)
- Bacillus subtilis (1)
- Bacterial infection (1)
- Bacteroides thetaiotaomicron (1)
- Bakterien (1)
- Bankart Läsion (1)
- Bauchspeicheldrüsenkrebs (1)
- Bericht (1)
- BioVaSc (1)
- Bioinformatik (1)
- Biologische Uhr (1)
- Biomarker (1)
- Biomedicine (1)
- Biomedizin (1)
- Blended Learning (1)
- Blut-Hirn-Schranke (1)
- Bordetella pertussis (1)
- Brain derived neurotorphic factor (1)
- Bronchialkarzinom (1)
- Brunelli (1)
- Bänderriss (1)
- C virus (1)
- C-tactile fibers (1)
- C. elegans (1)
- C5aR1-Antagonist (1)
- CARMO (1)
- CCL2 (1)
- CD8+ T cell differentiation (1)
- CD8+ T cells (1)
- CD8+ T-Zellen (1)
- CDK4 Inhibitor (1)
- CDK4 inhibitor (1)
- CIDP (1)
- CIP2A (1)
- CLAD (1)
- CRISPR-Cas (1)
- CRISPR/Cas-Methode (1)
- CRISPR/Cas9 (1)
- CRPS (1)
- CVT (1)
- Calcium (1)
- Candida albicans (1)
- Cas9 (1)
- CaseTrain (1)
- Caspr-1 (1)
- Chemische Synapsen (1)
- Children (1)
- Circadian (1)
- Collaborative Research Center (1)
- Colorectal cancer (1)
- Complement system (1)
- Complex Regional Pain Syndrome (1)
- Constant Score (1)
- Contactin-1 (1)
- Control centrality (1)
- Cost Analysis (1)
- Cruzi (1)
- Cytokine (1)
- DASH (1)
- DNA binding (1)
- DNA fragments (1)
- DNA sequencing (1)
- DNS (1)
- DPF3a (1)
- DUB Mutante (1)
- Democratic People's Republic of Korea (1)
- Dentalimplantat (1)
- Desmosom (1)
- Diabetes Mellitus (1)
- Diabetes mellitus (1)
- Diabetes mellitus / Typ 2 (1)
- Diabetes mellitus / Typ II (1)
- Dictyostelium discoideum (1)
- Dorsale Plikationsnaht (1)
- Drosophila (1)
- Drosophila melanogaster (1)
- Druckbelastung (1)
- Dual RNA-seq data analysis (1)
- EAE (1)
- ELISA (1)
- ESWT (1)
- Educational Measurement (I2.399) (1)
- Eigeninjektion / self injection (1)
- Electrospinning (1)
- Elektrokardiogramm (1)
- Embryonale Stammzellen (1)
- Encephalomyelitis (1)
- Endomyokardbiopsie (1)
- Endozytose (1)
- Entlassung (1)
- Epidemiologie (1)
- Epidermis (1)
- Epigenetik (1)
- Ethanol (1)
- Evidenz (1)
- Experimental Autoimmune Encephalomyelitis (EAE) (1)
- Experimental Biomedicine (1)
- Experimentelle Autoimmune Enzephalomyelitis (EAE) (1)
- Experimentelle Tumortherapie (1)
- F0 stability (1)
- FITT-STEMI-Studie (1)
- FOSL1 (1)
- Fabry disease (1)
- Faktor (1)
- Fettsucht (1)
- Fingergelenk (1)
- Fingergelenksversteifung (1)
- Fluorescence microscopy (1)
- Fluoreszenzmikroskopie (1)
- Fluoxetin (1)
- Foxp3+CD4+ regulatory T cell (1)
- GABA (1)
- GLA mutation (1)
- Gallensäuren (1)
- Gehhilfe (1)
- Gen-Knockout (1)
- Genetic regulatory networks (1)
- Genetics (1)
- Genexpression (1)
- Genome (1)
- Genregulation (1)
- Gephyrin (1)
- Glia (1)
- Glucose metabolism (1)
- Glucosyltransferase (1)
- Glukosemetabolismus (1)
- Glutathione (1)
- Gram-positive bacteria (1)
- Greifen (1)
- Griffkraft (1)
- Grundfrequenz (1)
- Guanylylcyclase (1)
- Guillain-Barré-Syndrom (1)
- HEY repressors (1)
- HNE (1)
- Hand (1)
- Handgelenksversteifung (1)
- Handkraft (1)
- Harnblasenkarzinom (1)
- HbA1c (1)
- Head-mounted Display (1)
- Hearing loss (1)
- Heart rate variability (1)
- Heilung (1)
- Hepatotoxizität (1)
- Herpes simplex (1)
- Herpes simplex Virus DUB C65A (1)
- Herpes simplex virus C65A (1)
- Herz (1)
- Herzinfarkt (1)
- Herzinfarktnetz (1)
- Herzinsuffizienz (1)
- Herzmuskelkrankheit (1)
- Hey-Gene (1)
- Hi-C (1)
- High energy, focused extracorporeal shock wave therapy (1)
- Hippokampus (1)
- Hirninfarkt (1)
- Histon-Demethylase UTX (1)
- Histone (1)
- Hochdosis-Glukokortikoidtherapie (1)
- Hochenergetische, fokussierte extrakorporale Stoßwellentherapie (1)
- Hormesis (1)
- Host defense (1)
- Host-pathogen interaction (1)
- Human Physiome (1)
- Hydrocortison (1)
- Hydrogen-peroxide (1)
- Hydroxymethyluracil (1)
- Hyperalgesie (1)
- Hypertonie (1)
- Hypoparathyreoidismus (1)
- Hypothalamus (1)
- Hämatopoese (1)
- Hörverlust (1)
- ICD (1)
- ICD-10 (1)
- ISIS (1)
- IgG-Subklasse (1)
- Ileus (1)
- Immunglobulin G (1)
- Immunology (1)
- Immunsystem (1)
- In-vitro (1)
- Increased Body Weight (1)
- Infektion (1)
- Inflammation (1)
- Inflammatory pain (1)
- Inhibitor (1)
- Inhibitorische Synapse (1)
- Inhibitory synapse (1)
- Innate immunity (1)
- Instabilität (1)
- Instrumentelle Analytik (1)
- Insulinresistenz (1)
- Interferon (1)
- Interleukin 6 (1)
- Intervallzeitmessung (1)
- Inzidenz (1)
- Inzidenz <Medizin> (1)
- Jitter (1)
- Joubert syndrome (1)
- Jugend (1)
- Kapselshift (1)
- Kapsulodese (1)
- Kardiovaskuläre Komorbiditäten (1)
- Kardiovaskuläre Krankheit (1)
- Katatonie (1)
- Katayama fever (1)
- Katdiotoxizität (1)
- Kenya (1)
- Kernspintomographie (1)
- Kinder (1)
- Kinesiotape (1)
- Kleine GTP-bindende Proteine (1)
- Knochenmark (1)
- Knock-Out (1)
- Knorpel (1)
- Kollagen I-Scaffold zum Sehnenersatz (1)
- Kollagen I-Scaffolds (1)
- Komplement (1)
- Komplement C5a (1)
- Komplement C5a Rezeptor 1 (1)
- Komplikationen dentaler Implantate (1)
- Komplimentärmedizin (1)
- Kontrollierte klinische Studie (1)
- Kopforthesentherapie (1)
- Kraftmessung (1)
- Kraftverteilung (1)
- Körperliche Belastbarkeit (1)
- LASP-1 (1)
- LIN9 (1)
- LOH (1)
- Lactatdehydrogenase (1)
- Lactobacillus reuteri (1)
- Lagerungsplagiozephalus (1)
- Laufbandtraining (1)
- Lebertoxizität (1)
- Li Fraumeni Syndrom (1)
- Li Fraumeni syndrome (1)
- Ligand (1)
- Ligand-Rezeptor-Interaktion (1)
- Lymphknoten (1)
- Lymphotoxin (1)
- MATQ-seq (1)
- MAX (1)
- MLC (1)
- MLC1 (1)
- MMN (1)
- MR-Morphologie (1)
- MRI (1)
- MYC (1)
- MYCN (1)
- Machine learning (1)
- Magnetresonanztomographie (1)
- Makrophage (1)
- Makrophagen (1)
- Mansoni infection (1)
- Manugraphy-System (1)
- Maschinelles Lernen (1)
- Medulloblastom (1)
- Melanom (1)
- Membrane transporters (1)
- Membranlipide (1)
- Membrantransporter (1)
- Mena/VASP (1)
- Meningokokken-Sepsis (1)
- Mensch (1)
- Messenger RNA (1)
- Metabolism (1)
- Methohexital (1)
- Methylation (1)
- Mikroglia (1)
- Mittelkörper (1)
- Molekularbiologie (1)
- Monozyten (1)
- Moosfaserterminalen (1)
- Motivation (1)
- Muliples Myelom (1)
- Multiple Sclerosis (1)
- Multiple-Choice Examination (1)
- Multiple-Choice Prüfungen (1)
- Muster-ERG (1)
- Mutationen (1)
- Mutter-Kind-Maßnahme (1)
- Mutterkindkur (1)
- Mutterkindvorsorge (1)
- Myokard (1)
- Myokardinfarkt (1)
- Myokarditis (1)
- NNMT (1)
- NNMT activity assay (1)
- Nachuntersuchung (1)
- Nasenschleimhaut (1)
- Natriumoxamat (1)
- Navigation (1)
- Nebenniereninsuffizienz / adrenal insufficiency (1)
- Nebennierenkrise / adrenal crisis (1)
- Nebennierenrinde (1)
- Nebennierenrindeninsuffizienz (1)
- Nebennierenrindenkarzinom (1)
- Nervenstammzelle (1)
- Neurodegeneration (1)
- Neuroinflammation (1)
- Neurorehabilitation (1)
- Neurotizismus (1)
- Neutrophil granulocyte (1)
- Neutrophiler Granulozyt (1)
- Neutrophils (1)
- Nichtlineare Differentialgleichung (1)
- Nigeria (1)
- Nodo-Paranodopathie (1)
- Noonan-Syndrom (1)
- Notch-Signalweg (1)
- Nrf2 (1)
- Obesity (1)
- Omega-3-Fettsäuren (1)
- Onkologie (1)
- Operation (1)
- Optogenetics (1)
- Optogenetik (1)
- Orientia tsutsugamushi (1)
- Osseointegartion (1)
- Osseointegration (1)
- Outlier detection (1)
- OxPL (1)
- Oxford Shoulder Instability Score (1)
- Oxidative Stress (1)
- Oxidative stress (1)
- Oxidativer Stress (1)
- Oxidized phospholipids (1)
- Oxygen (1)
- PAF1c (1)
- PARROT (1)
- PDE3 (1)
- PKD1 (1)
- PP2A (1)
- PPI (1)
- PPQ (1)
- Palbociclib (1)
- Pam2Cys (1)
- Parasite (1)
- Patient Simulation (1)
- Pattern classification (1)
- Peptidsynthese (1)
- Phagozytose (1)
- Pharmakokinetik (1)
- Pharmakokinetik / pharmacokinetics (1)
- Pioglitazon (1)
- Polymorphismen (1)
- Polyneuropathie (1)
- Polyphenols (1)
- Primärelement (1)
- Primärprevention (1)
- Primärzellen (1)
- Problem Based Learning (1)
- Problembasiertes Lernen (1)
- Prognose (1)
- Proliferation (1)
- Propofol (1)
- Prostatakarzinom (1)
- Prostatakrebs (1)
- Protein Kinase D (1)
- Protein Kinase D 1 (1)
- Prädiktoren (1)
- Präzisionsmedizin (1)
- Pseudarthrose (1)
- Psychische Belastung (1)
- Psychische Gesundheit (1)
- Psychophysiologische Diagnostik (1)
- Pulmonale Hypertonie (1)
- R337H (1)
- RAL (1)
- RNA polymerase (1)
- RNA sequencing (RNA-Seq) (1)
- RNA structure (1)
- RNA virus (1)
- RNA-binding proteins (1)
- RNA-seq (1)
- RNS-Interferenz (1)
- Rachitis (1)
- Ranvier-Schnürring (1)
- Ratte (1)
- Raucher (1)
- RbdB (1)
- Redox environment (1)
- Rehabilitation (1)
- Rekanalisation Hirninfarkt (1)
- Resilienz (1)
- Retrosepektiv (1)
- Rezidivluxationen (1)
- Rituximab (1)
- SABR (1)
- SARS-CoV-2 (1)
- SBRT (1)
- SGLT (1)
- SHIP-TREND (1)
- SIS-muc (1)
- SL-Bandnaht (1)
- SL-Bandruptur (1)
- STEMI (1)
- Salmonella enterica (1)
- Sarkoidose (1)
- Sauerstoffkonzentration (1)
- Schizophrenie (1)
- Schlaf (1)
- Schleuse (1)
- Schmerzen (1)
- Schultergelenk (1)
- Schultergelenkluxation (1)
- Schultergelenkverletzung (1)
- Sehnenersatz (1)
- Sekundäre Inflammation (1)
- Selektiver Serotonin Wiederaufnahmehemmer / SSRI (1)
- Self-Evaluation Programs (I2.399.780) (1)
- Shigella flexneri (1)
- Shimmer (1)
- Signaltransduktion (1)
- Simulation (1)
- Sinorhizobium fredii (1)
- Sinusthrombose (1)
- Skin (1)
- Sleep (1)
- Sleeping Beauty Transposon System (1)
- Solid-phase peptide synthesis (1)
- Sonderforschungsbereich Transregio 240 (1)
- Spatiotemporal analysis (1)
- Speicheldrüse (1)
- Sphingolipid biology (1)
- Sphingolipide (1)
- Spred-Proteine (1)
- Staphylococcus aureus (1)
- Startle (1)
- Stent Retriever Schlaganfall (1)
- Stimmstabilität (1)
- Stoffwechsel (1)
- Stoffwechselinhibitoren (1)
- Support Vector Machine (1)
- Surveillance (1)
- T-Zelle (1)
- TAC (1)
- TKI (1)
- TLR3 (1)
- TNF Superfamilie (1)
- TNFR2 (1)
- Tagesrhythmus (1)
- Tanzania (1)
- Teaching (1)
- Thrombolysis stroke (1)
- Tissue Engineering (1)
- Toll-like receptor (1)
- Toll-like-Rezeptor (1)
- Trainingsfall (1)
- Trans-reservatrol (1)
- Transcription initiation (1)
- Transferases (1)
- Transkriptionsfaktor (1)
- Transkriptomanalyse (1)
- Transposon (1)
- Treadmill training (1)
- Trypanosoma brucei (1)
- Trypanosoma brucei brucei (1)
- Trypanosoma-brucei (1)
- Tumorhypoxie (1)
- Tumorzelle (1)
- Typhoid-fever (1)
- UHPLC (1)
- UHPLC-ESI-MS/MS (1)
- Uganda (1)
- Unconventional T cells (1)
- Urothelkarzinom (1)
- VSG (1)
- Verkalkung (1)
- Virtuelle Realität (1)
- Virusreplikation (1)
- Vitamin D (1)
- Vitamin D Mangel (1)
- Vitamin-D-Mangel (1)
- WHO-Klassifikation 2007 (1)
- Wachstumsfaktor (1)
- Warburg, Otto (1)
- Warburg-Effekt (1)
- Wilms tumor (1)
- Wundheilung (1)
- Xerostomie (1)
- Zelldifferenzierung (1)
- Zellkern (1)
- Zellkernarchitektur (1)
- Zellkultur (1)
- Zellzyklus (1)
- Zellüberleben (1)
- Zufriedenheitsanalyse (1)
- Zylindergriff (1)
- abscission (1)
- acquired immunodeficiency-syndrome (1)
- actin (1)
- active zone (1)
- adipocyte (1)
- adipose (1)
- adjuvant (1)
- adolescent (1)
- adrenocortical carcinoma (1)
- adult neurogenesis (1)
- affect-regulating massage therapy (1)
- affective touch (1)
- agomelatine (1)
- alfa-cyano-4-hydroxycinnamat (1)
- analysis of variance (1)
- angiography (1)
- anorexia nervosa (1)
- anticoagulants (1)
- antigenic variation (1)
- antimicrobial stewardship (1)
- anxiolytics (1)
- associative memory (1)
- atonia (1)
- atrial fibrillation (1)
- autonomic balance (1)
- autonomic nervous system (1)
- behavior (1)
- biomarker (1)
- bladder cancer (1)
- blood (1)
- blood brain barrier (1)
- body psychotherapy (1)
- body weight regulation (1)
- bone metastases (1)
- bone microenvironment (1)
- breast cancer (1)
- c-Myc (1)
- cAMP (1)
- cGMP (1)
- cGMP/cAMP-Crosstalk (1)
- cardiac hypertrophy (1)
- cardiac surgery (1)
- cardiopulmonary exercise testing (1)
- cardiotoxicity (1)
- cardiovascular magnetic resonance (1)
- cartilage (1)
- central lung (1)
- chemotherapy (1)
- childhood and adolescence (1)
- children (1)
- chromosome conformation capture (1)
- chronic thromboembolic pulmonary hypertension (1)
- cirrhosis (1)
- cleft lip and palate (1)
- clinical trials (1)
- congenital ocular motor apraxia (1)
- contact (1)
- contrast (1)
- coronary disease (1)
- cruzi (1)
- cylinder gripping (1)
- delayed bone healing (1)
- denosumab (1)
- dialysepflichtige Niereninsuffizienz (1)
- differentiated thyroid carcinoma (1)
- dilated cardiomyopathy (1)
- double-strand break repair (1)
- drug (1)
- drugs (1)
- dsRNA binding protein (1)
- dyspnea (1)
- eicosanoids (1)
- emission-computed-tomography (1)
- emotions (1)
- endomyocardial biopsy (1)
- endovascular recanalization stroke (1)
- endovaskuläre Therapie Hirninfarkt (1)
- epithelial-to-mesenchymal transition (1)
- esophagoscopy (1)
- etiology (1)
- evolution (1)
- execise capacity (1)
- fMRI (1)
- fMRI time series (1)
- face (1)
- facet joint degeneration (1)
- facet joint injection (1)
- feigned loss of strength (1)
- finger joint fusion (1)
- fluorescence (1)
- follow-up (1)
- foxes vulpes-vulpes (1)
- fruit-flies (1)
- fundamental frequency (1)
- funktionelle Kernspintomographie (1)
- gastrointestinal motility (1)
- gastrointestinale Motilität (1)
- gastronintestinal microbiota (1)
- gefitinib (1)
- gene expression heterogeneity (1)
- genes (1)
- genome packaging (1)
- genotype (1)
- gezielte Therapie (1)
- glucocorticoid receptor (1)
- glycolysis (1)
- gp130 (1)
- guanosine (1)
- guide effiiciency (1)
- haematobium (1)
- haemostasis (1)
- health (1)
- health care workers (1)
- heart (1)
- heart rate (1)
- helminths (1)
- hepatitis B (1)
- hepatitis B virus (1)
- hepatitis C virus (1)
- herpes simplex (1)
- hippocampus (1)
- histone H3 (1)
- histone variants (1)
- human adipose tissue (1)
- human african trypanosomiasis (1)
- human cell nucleus (1)
- human-immunodeficiency-virus (1)
- hypoxanthine (1)
- iberis amara extract (1)
- immune evasion (1)
- immunodiagnosis (1)
- in vitro (1)
- in vitro Kulturmodelle (1)
- in vitro Testsystem (1)
- incidence (1)
- inconsistencies (1)
- injury prevention (1)
- innate immunity (1)
- inosine (1)
- insertable cardiac monitor (1)
- insulin resistance (1)
- interactome (1)
- interoception (1)
- intervention (1)
- intestinal mucus (1)
- intravenöse Immunglobuline (1)
- invasive cysticerocsis (1)
- iodine-131 (1)
- ischemia (1)
- ischemic stroke (1)
- japonicum (1)
- kieferorthopädische Frühbehandlung (1)
- kolorektale Karzinomzelllinien (1)
- konditioneller Knockout (1)
- late-onset (1)
- ligation (1)
- lipid rafts (1)
- load distribution (1)
- long ncRNA (1)
- long-term complications (1)
- lumbar degenerative disease (1)
- lumbar spinal stenosis (1)
- lung cancer (1)
- lyso-Gb3 (1)
- machine learning (1)
- macrophage (1)
- managing big data (1)
- mass vaccination (1)
- massage therapy (1)
- match load (1)
- mechanical thrombectomy stroke (1)
- mechanische Thrombektomie (1)
- mechanism (1)
- medicine (1)
- megakaryocytes (1)
- melatonin (1)
- mental health (1)
- metabolism (1)
- metagenomics (1)
- metaproteomics (1)
- metatranscriptomics (1)
- miR-223-5p (1)
- miRNS (1)
- microalga-bacteria interaction (1)
- microbiology (1)
- microbiota (1)
- microprocessor (1)
- midbody (1)
- mitosis (1)
- molar tooth sign (1)
- molecular alterations (1)
- mossy fiber terminal (1)
- multiple myeloma (1)
- murine (1)
- mutation (1)
- mutation screening (1)
- mutually exclusive expression (1)
- myocardial infarction (1)
- myocarditis (1)
- natural genetic variation (1)
- nesbitti (1)
- neuroendocrine neoplasms (1)
- non-contact´ (1)
- non-union (1)
- noninvasive detection (1)
- nuclear architecture (1)
- obere Extremität (1)
- obesity (1)
- off-targets (1)
- omega-3 fatty acids (1)
- onkologische Patienten (1)
- opponent processes (1)
- oro-faziale Spaltbildungen (1)
- outbreak (1)
- p53 (1)
- pain (1)
- pancreatic cancer (1)
- parasitology (1)
- parasomn (1)
- patient (1)
- perfusion (1)
- periodische Katatonie (1)
- phagocytosis (1)
- phosphorylation (1)
- phycosphere biofilm (1)
- pioglitazone (1)
- pkd (1)
- plant symbioses (1)
- plasmid copy number (1)
- point-of-care test (1)
- polymorphism (1)
- post-transcriptional regulation (1)
- postradiogene Xerostomie (1)
- pre-analytical variation (1)
- pre-orthodontic treatment (1)
- precision medicine (1)
- prevention (1)
- primary prophylaxis (1)
- prognosis (1)
- prognostic awareness (1)
- prognostic value (1)
- protein (1)
- psychische Beschwerden (1)
- psychoactive massage (1)
- pulmonary artery (1)
- pulmonary artery pressure (1)
- pulmonary circulation (1)
- pulmonary embolism (1)
- pulmonary hypertension (1)
- pulmonary toxicity (1)
- punishment (1)
- quality indicators (1)
- quality of life (1)
- questionnaires (1)
- quorum sensing (QS) (1)
- rRNA depletion (1)
- radioiodine therapy (1)
- randomized-trial (1)
- rats (1)
- reactive oxygen species (1)
- reaktive Sauerstoffradikale (1)
- refeeding syndrome (1)
- relief (1)
- renal failure requiring hemodialysis (1)
- renale Kalzifikationen (1)
- repositories (1)
- reproducible science (1)
- respiratory pump (1)
- reverse genetics (1)
- reward (1)
- sRNA atlas (1)
- scintigraphy (1)
- second primary malignancy (1)
- serial RNA interactome capture (1)
- seroprevalence (1)
- service infrastructure (1)
- side effects (1)
- single-cell RNA-seq (1)
- skeletal-related events (1)
- sleep-related eating (1)
- sleeping sickness (1)
- social anxiety disorder (1)
- spatial organization (1)
- spectrin (1)
- standards (1)
- steerable sheath (1)
- stent retriever stroke (1)
- steuerbare Schleuse (1)
- streptozotocin (1)
- stress perfusion (1)
- stroke prevention (1)
- stroke treatment (1)
- subkutan / subcutaneous (1)
- submaximal effort (1)
- submaximal force measurement (1)
- submaximale Kraftanstrengung (1)
- submaximale Kraftmessung (1)
- surgical antimicrobial prophylaxis (1)
- surgical site infections (1)
- sustained fear (1)
- syphilis (1)
- targeted re-sequencing (1)
- targeted therapy (1)
- test system (1)
- therapy (1)
- time-to-centrifugation (1)
- tool (1)
- transcription factors (1)
- transcription start sites (1)
- transitional cell carcinoma (1)
- transport (1)
- travelers (1)
- upper extremity (1)
- upstream regulator (1)
- urine samples (1)
- vaccine (1)
- variant of unknown significance (1)
- variant surface glycoprotein (1)
- vegetarians (1)
- verzögerte Heilung (1)
- viral assembly (1)
- virtual reality (1)
- vorgetäuschter Kraftverlust (1)
- weight loss (1)
- women (1)
- wound healing (1)
- wrist fusion (1)
- young females (1)
- Ätiologie (1)
- Überlebensrate dentaler Implantate (1)
Institute
- Medizinische Fakultät (161)
- Graduate School of Life Sciences (44)
- Theodor-Boveri-Institut für Biowissenschaften (8)
- Rudolf-Virchow-Zentrum (6)
- Fakultät für Biologie (4)
- Missionsärztliche Klinik (4)
- Lehrstuhl für Orthopädie (3)
- Institut für Informatik (2)
- Institut für Molekulare Infektionsbiologie (2)
- Institut für Psychologie (2)
Sonstige beteiligte Institutionen
- Comprehensive Cancer Center Mainfranken (2)
- Helmholtz Institute for RNA-based Infection Research (HIRI) (2)
- Lehrkrankenhaus II. Medizinische Klinik Klinikum Coburg (2)
- Bayer AG, Research & Development, Pharmaceuticals, Investigational Toxicology (1)
- Boston Children's Hospital (1)
- Comprehensive Heart Failure Center Wuerzburg (CHFC) (1)
- Eberhard Karls Universität Tübingen (1)
- Institut für diagnostische und interventionelle Radiologie, Klinikum Ingolstadt (1)
- Interdisciplinary Bank of Biological Material and Data Würzburg (IBDW) (1)
- Juliusspital, Würzburg (1)
Bone represents a common site of metastases for several solid tumors. However, the ability of neuroendocrine neoplasms (NENs) to localize to bone has always been considered a rare and late event. Thanks to the improvement of therapeutic options, which results in longer survival, and of imaging techniques, particularly after the introduction of positron emission tomography (PET) with gallium peptides, the diagnosis of bone metastases (BMs) in NENs is increasing. The onset of BMs can be associated with severe skeletal complications that impair the patient's quality of life. Moreover, BMs negatively affect the prognosis of NEN patients, bringing out the lack of curative treatment options for advanced NENs. The current knowledge on BMs in gastro-entero-pancreatic (GEP) and bronchopulmonary (BP) NENs is still scant and is derived from a few retrospective studies and case reports. This review aims to perform a critical analysis of the evidence regarding the role of BMs in GEP- and BP-NENs, focusing on the molecular mechanisms underlining the development of BMs, as well as clinical presentation, diagnosis, and treatment of BMs, in an attempt to provide suggestions that can be used in clinical practice.
Colorectal cancer (CRC) is the second most common tumour disease in Germany, with the sequential accumulation of certain mutations playing a decisive role in the transition from adenoma to carcinoma. In particular, deregulation of the Wnt signalling pathway and the associated deregulated expression of the MYC oncoprotein play a crucial role. Targeting MYC thus represents an important therapeutic approach in the treatment of tumours. Since direct inhibition of MYC is challenging, various approaches have been pursued to date to target MYC indirectly. The MYC 5' UTR contains an internal ribosomal entry site (IRES), which has a particular role in the initiation of MYC translation, especially in multiple myeloma. As basis for this work, it was hypothesised on the basis of previous data that translation of MYC potentially occurs via its IRES in CRC as well. Based on this, two IRES inhibitors were tested for their potential to regulate MYC expression in CRC cells. In addition, alternative, 5’ UTR-dependent translation of MYC and interacting factors were investigated. EIF3D was identified as a MYC 5' UTR binding protein which has the potential to regulate MYC expression in CRC. The results of this work suggest that there is a link between eIF3D and MYC expression/translation, rendering eIF3D a potential therapeutic target for MYC-driven CRCs.
Among the defense strategies developed in microbes over millions of years, the innate adaptive CRISPR-Cas immune systems have spread across most of bacteria and archaea. The flexibility, simplicity, and specificity of CRISPR-Cas systems have laid the foundation for CRISPR-based genetic tools. Yet, the efficient administration of CRISPR-based tools demands rational designs to maximize the on-target efficiency and off-target specificity. Specifically, the selection of guide RNAs (gRNAs), which play a crucial role in the target recognition of CRISPR-Cas systems, is non-trivial. Despite the fact that the emerging machine learning techniques provide a solution to aid in gRNA design with prediction algorithms, design rules for many CRISPR-Cas systems are ill-defined, hindering their broader applications.
CRISPR interference (CRISPRi), an alternative gene silencing technique using a catalytically dead Cas protein to interfere with transcription, is a leading technique in bacteria for functional interrogation, pathway manipulation, and genome-wide screens. Although the application is promising, it also is hindered by under-investigated design rules. Therefore, in this work, I develop a state-of-art predictive machine learning model for guide silencing efficiency in bacteria leveraging the advantages of feature engineering, data integration, interpretable AI, and automated machine learning. I first systematically investigate the influential factors that attribute to the extent of depletion in multiple CRISPRi genome-wide essentiality screens in Escherichia coli and demonstrate the surprising dominant contribution of gene-specific effects, such as gene expression level. These observations allowed me to segregate the confounding gene-specific effects using a mixed-effect random forest (MERF) model to provide a better estimate of guide efficiency, together with the improvement led by integrating multiple screens. The MERF model outperformed existing tools in an independent high-throughput saturating screen. I next interpret the predictive model to extract the design rules for robust gene silencing, such as the preference for cytosine and disfavoring for guanine and thymine within and around the protospacer adjacent motif (PAM) sequence. I further incorporated the MERF model in a web-based tool that is freely accessible at www.ciao.helmholtz-hiri.de.
When comparing the MERF model with existing tools, the performance of the alternative gRNA design tool optimized for CRISPRi in eukaryotes when applied to bacteria was far from satisfying, questioning the robustness of prediction algorithms across organisms. In addition, the CRISPR-Cas systems exhibit diverse mechanisms albeit with some similarities. The captured predictive patterns from one dataset thereby are at risk of poor generalization when applied across organisms and CRISPR-Cas techniques. To fill the gap, the machine learning approach I present here for CRISPRi could serve as a blueprint for the effective development of prediction algorithms for specific organisms or CRISPR-Cas systems of interest. The explicit workflow includes three principle steps: 1) accommodating the feature set for the CRISPR-Cas system or technique; 2) optimizing a machine learning model using automated machine learning; 3) explaining the model using interpretable AI. To illustrate the applicability of the workflow and diversity of results when applied across different bacteria and CRISPR-Cas systems, I have applied this workflow to analyze three distinct CRISPR-Cas genome-wide screens. From the CRISPR base editor essentiality screen in E. coli, I have determined the PAM preference and sequence context in the editing window for efficient editing, such as A at the 2nd position of PAM, A/TT/TG downstream of PAM, and TC at the 4th to 5th position of gRNAs. From the CRISPR-Cas13a screen in E. coli, in addition to the strong correlation with the guide depletion, the target expression level is the strongest predictor in the model, supporting it as a main determinant of the activation of Cas13-induced immunity and better characterizing the CRISPR-Cas13 system. From the CRISPR-Cas12a screen in Klebsiella pneumoniae, I have extracted the design rules for robust antimicrobial activity across K. pneumoniae strains and provided a predictive algorithm for gRNA design, facilitating CRISPR-Cas12a as an alternative technique to tackle antibiotic resistance.
Overall, this thesis presents an accurate prediction algorithm for CRISPRi guide efficiency in bacteria, providing insights into the determinants of efficient silencing and guide designs. The systematic exploration has led to a robust machine learning approach for effective model development in other bacteria and CRISPR-Cas systems. Applying the approach in the analysis of independent CRISPR-Cas screens not only sheds light on the design rules but also the mechanisms of the CRISPR-Cas systems. Together, I demonstrate that applied machine learning paves the way to a deeper understanding and a broader application of CRISPR-Cas systems.
Colorectal Cancer (CRC) is the third most common cancer in the US. The majority of CRC cases are due to deregulated WNT-signalling pathway. These alterations are mainly caused by mutations in the tumour suppressor gene APC or in CTNNB1, encoding the key effector protein of this pathway, β-Catenin. In canonical WNT-signalling, β-Catenin activates the transcription of several target genes, encoding for proteins involved in proliferation, such as MYC, JUN and NOTCH. Being such a critical regulator of these proto-oncogenes, the stability of β-Catenin is tightly regulated by the Ubiquitin-Proteasome System. Several E3 ligases that ubiquitylate and degrade β-Catenin have been described in the past, but the antagonists, the deubiquitylases, are still unknown. By performing an unbiased siRNA screen, the deubiquitylase USP10 was identified as a de novo positive regulator of β-Catenin stability in CRC derived cells. USP10 has previously been shown in the literature to regulate both mutant and wild type TP53 stability, to deubiquitylate NOTCH1 in endothelial cells and to be involved in the regulation of AMPKα signalling. Overall, however, its role in colorectal tumorigenesis remains controversial. By analysing publicly available protein and gene expression data from colorectal cancer patients, we have shown that USP10 is strongly upregulated or amplified upon transformation and that its expression correlates positively with CTNNB1 expression. In contrast, basal USP10 levels were found in non-transformed tissues, but surprisingly USP10 is upregulated in intestinal stem cells. Endogenous interaction studies in CRC-derived cell lines, with different extend of APCtruncation, revealed an APC-dependent mode of action for both proteins. Furthermore, by utilising CRISPR/Cas9, shRNA-mediated knock-down and overexpression of USP10, we could demonstrate a regulation of β-Catenin stability by USP10 in CRC cell lines. It is widely excepted that 2D cell culture systems do not reflect complexity, architecture and heterogeneity and are therefore not suitable to answer complex biological questions. To overcome this, we established the isolation, cultivation and genetically modification of murine intestinal organoids and utilised this system to study Usp10s role ex vivo. By performing RNA sequencing, dependent on different Usp10 levels, we were able to recapitulate the previous findings and demonstrated Usp10 as important regulator of β-dependent regulation of stem cell homeostasis. Since genetic depletion of USP10 resulted in down-regulation of β-Catenin-dependent transcription, therapeutic intervention of USP10 in colorectal cancer was also investigated. Commercial and newly developed inhibitors were tested for their efficacy against USP10, but failed to significantly inhibit USP10 activity in colorectal cancer cells. To validate the findings from this work also in vivo, development of a novel mouse model for colorectal cancer has begun. By combining CRISPR/Cas9 and classical genetic engineering with viral injection strategies, WT and genetically modified mice could be transformed and, at least in some animals, intestinal lesions were detectable at the microscopic level. The inhibition of USP10, which we could describe as a de novo tumour-specific regulator of β-Catenin, could become a new therapeutic strategy for colorectal cancer patients.
The immune system is responsible for the preservation of homeostasis whenever a given organism is exposed to distinct kinds of perturbations. Given the complexity of certain organisms like mammals, and the diverse types of challenges that they encounter (e.g. infection or disease), the immune system evolved to harbor a great variety of distinct immune cell populations with specialized functions. For instance, the family of T cells is sub-divided into conventional (Tconv) and unconventional T cells (UTCs). Tconv form part of the adaptive arm of the immune system and are comprised of αβ CD4+ or CD8+ cells that differentiate from naïve to effector and memory populations upon activation and are essential during infection and cancer. Furthermore, UTCs, which include γδ T cells, NKT and MAIT, are involved in innate and adaptive immune responses, due to their dual mode of activation, through cytokines (innate-like) or TCR (adaptive), and function. Despite our understanding of the basic functions of T cells in several contexts, a great number of open questions related to their basic biology remain. For instance, the mechanism behind the differentiation of naïve CD4+ and CD8+ T cells into effector and memory populations is not fully understood. Moreover, the exact function and relevance of distinct UTC subpopulations in a physiological context have not been fully clarified. Here, we investigated the factors mediating naïve CD8+ T cell differentiation into effector and memory cells. By using flow cytometry, mass spectrometry, enzymatic assays, and transgenic mouse models, we found that the membrane bound enzyme sphingomyelin-phosphodiesterase acid-like 3b (Smpdl3b) is crucial for the maintenance of memory CD8+ T cells. Our data show that the absence of Smpdl3b leads to diminished CD8+ T cell memory, and a loss of stem-like memory populations due to an aggravated contraction. Our scRNA-seq data suggest that Smpdl3b could be involved in clathrinmediated endocytosis through modulation of Huntingtin interacting protein 1 (Hip1) levels, likely regulating TCR-independent signaling events. Furthermore, in this study we explored the role of UTCs in lymph node-specific immune responses. By using transgenic mouse models for photolabeling, lymph node transplantation models, infection models and flow cytometry, we demonstrate that S1P regulates the migration of tissue-derived UTC from tissues to draining lymph nodes, resulting in heterogeneous immune responses mounted by lymph nodes draining different tissues. Moreover, our unbiased scRNAseq and single lineage-deficient mouse models analysis revealed that all UTC lineages (γδ T cells, NKT and MAIT) are organized in functional units, based on transcriptional homogeneity, shared microanatomical location and migratory behavior, and numerical and functional redundancy. Taken together, our studies describe additional cell intrinsic (Smpdl3b) and extrinsic (S1Pmediated migration) functions of sphingolipid metabolism modulating T cell biology. We propose the S1P/S1PR1/5 signaling axis as the potential survival pathway for Smpdl3b+ memory CD8+ T cells and UTCs, mainly in lymph nodes. Possibly, Smpdl3b regulates S1P/S1PR signaling by balancing ligandreceptor endocytosis, while UTCs migrate to lymph nodes during homeostasis to be exposed to specific levels of S1P that assure their maintenance. Our results are clinically relevant, since several drugs modulating the S1P/S1PR signaling axis or the levels of Smpdl3b are currently used to treat human diseases, such as multiple sclerosis and B cell-mediated diseases. We hope that our discoveries will inspire future studies focusing on sphingolipid metabolism in immune cell biology.
Kardiovaskuläre und renale Komorbiditäten in Zusammenhang mit chronischem Hypoparathyreoidismus
(2024)
Der cHPT ist eine seltene Erkrankung, die durch zu niedriges Kalzium im Serum aufgrund einer zu geringen PTH-Sekretion über 6 Monate charakterisiert ist. Auch bei Patienten mit einem gut kontrollierten cHPT treten Komorbiditäten und Langzeitkomplikationen auf, die jedoch bisher kaum in prospektiven Studien untersucht wurden.
Ziel dieser Arbeit war es daher, im Rahmen einer systematischen und prospektiv erfassten Studie das Auftreten kardiovaskulärer und renaler Komorbiditäten bei Patienten mit cHPT zu untersuchen und mögliche Prädiktoren für diese zu ermitteln. Außerdem erfolgte ein Vergleich mit gematchten Kontrollgruppen der deutschen Normalbevölkerung mithilfe der SHIP-TREND Studie.
Patienten mit cHPT zeigten eine signifikant höhere QTc-Zeit, eine höhere Prävalenz für QTc-Zeit-Verlängerung und signifikant höhere systolische und diastolische Blutdruckwerte trotz tendenziell, jedoch nicht signifikant, häufigerer Einnahme antihypertensiver Medikamente. In der Echokardiographie lagen eine geringere linksventrikuläre Masse, eine geringere Prävalenz für linksventrikuläre Hypertrophie und signifikant häufiger Klappenstenosen vor.
Eine renale Insuffizienz lag mit 21% der Patienten mit cHPT signifikant häufiger als bei gesunden Kontrollpersonen vor. Die Prävalenz renaler Kalzifikationen betrug 9,6%.
Mögliche Risikofaktoren für das Auftreten kardiovaskulärer und renaler Komorbiditäten bei cHPT sind weiterhin unklar. In dieser Studie zeigte sich eine mögliche Assoziation zwischen den Elektrolytstörungen wie Hyperphosphatämie und Hypomagnesiämie, der Hyperkalziurie und dem PTH-Mangel mit valvulären, vaskulären und renalen Kalzifikationen sowie den Blutdruckwerten und der Nierenfunktion.
Demnach erscheint eine Überwachung der Serumelektrolyte sowie der Kalziumausscheidung im Urin notwendig und essenziell. Auch die Bedeutung der PTH-Ersatztherapie ist weiterhin im Hinblick auf die Prävention kardiovaskulärer und renaler Erkrankungen unklar.
Besides their central role in haemostasis and thrombosis, platelets are increasingly recognised as versatile effector cells in inflammation, the innate and adaptive immune response, extracellular matrix reorganisation and fibrosis, maintenance of barrier and organ integrity, and host response to pathogens. These platelet functions, referred to as thrombo-inflammation and immunothrombosis, have gained major attention in the COVID-19 pandemic, where patients develop an inflammatory disease state with severe and life-threatening thromboembolic complications. In the CRC/TR 240, a highly interdisciplinary team of basic, translational and clinical scientists explored these emerging roles of platelets with the aim to develop novel treatment concepts for cardiovascular disorders and beyond. We have i) unravelled mechanisms leading to life-threatening thromboembolic complica-tions following vaccination against SARS-CoV-2 with adenoviral vector-based vaccines, ii) identified unrecognised functions of platelet receptors and their regulation, offering new potential targets for pharmacological intervention and iii) developed new methodology to study the biology of megakar-yocytes (MKs), the precursor cells of platelets in the bone marrow, which lay the foundation for the modulation of platelet biogenesis and function. The projects of the CRC/TR 240 built on the unique expertise of our research network and focussed on the following complementary fields: (A) Cell bi-ology of megakaryocytes and platelets and (B) Platelets as regulators and effectors in disease. To achieve this aim, we followed a comprehensive approach starting out from in vitro systems and animal models to clinical research with large prospective patient cohorts and data-/biobanking. Despite the comparably short funding period the CRC/TR 240 discovered basic new mechanisms of platelet biogenesis, signal transduction and effector function and identified potential MK/platelet-specific molecular targets for diagnosis and therapy of thrombotic, haemorrhagic and thrombo-inflammatory disease states.
Purpose
The purpose of this study is to investigate changes over time in quality of life (QoL) in incurable lung cancer patients and the impact of determinants like molecular alterations (MA).
Methods
In a prospective, longitudinal, multicentric study, we assessed QoL, symptom burden, psychological distress, unmet needs, and prognostic understanding of patients diagnosed with incurable lung cancer at the time of the diagnosis (T0) and after 3 (T1), 6 (T2) and 12 months (T3) using validated questionnaires like FACT-L, National Comprehensive Cancer Network (NCCN) Distress Thermometer (DT), PHQ-4, SCNS-SF-34, and SEIQoL.
Results
Two hundred seventeen patients were enrolled, 22 (10%) with reported MA. QoL scores improved over time, with a significant trend for DT, PHQ-4, and SCNS-SF-34. Significant determinants for stable or improving scores over time were survival > 6 months, performance status at the time of diagnosis, and presence of MA. Patients with MA showed better QoL scores (FACT-L at T1 104.4 vs 86.3; at T2 107.5 vs 90.0; at T3 100.9 vs 92.8) and lower psychological distress (NCCN DT at T1 3.3 vs 5; at T2 2.7 vs 4.5; at T3 3.7 vs 4.5; PHQ-4 at T1 2.3 vs 4.1; at T2 1.7 vs 3.6; at T3 2.2 vs 3.6), but also a worsening of the scores at 1 year and a higher percentage of inaccurate prognostic understanding (27 vs 17%) compared to patients without MA.
Conclusion
Patients with tumors harboring MA are at risk of QoL deterioration during the course of the disease. Physicians should adapt their communication strategies in order to maintain or improve QoL.
Bulk RNA sequencing technologies have provided invaluable insights into host and bacterial gene expression and associated regulatory networks. Nevertheless, the majority of these approaches report average expression across cell populations, hiding the true underlying expression patterns that are often heterogeneous in nature. Due to technical advances, single-cell transcriptomics in bacteria has recently become reality, allowing exploration of these heterogeneous populations, which are often the result of environmental changes and stressors. In this work, we have improved our previously published bacterial single-cell RNA sequencing (scRNA-seq) protocol that is based on multiple annealing and deoxycytidine (dC) tailing-based quantitative scRNA-seq (MATQ-seq), achieving a higher throughput through the integration of automation. We also selected a more efficient reverse transcriptase, which led to reduced cell loss and higher workflow robustness. Moreover, we successfully implemented a Cas9-based rRNA depletion protocol into the MATQ-seq workflow. Applying our improved protocol on a large set of single Salmonella cells sampled over different growth conditions revealed improved gene coverage and a higher gene detection limit compared to our original protocol and allowed us to detect the expression of small regulatory RNAs, such as GcvB or CsrB at a single-cell level. In addition, we confirmed previously described phenotypic heterogeneity in Salmonella in regard to expression of pathogenicity-associated genes. Overall, the low percentage of cell loss and high gene detection limit makes the improved MATQ-seq protocol particularly well suited for studies with limited input material, such as analysis of small bacterial populations in host niches or intracellular bacteria.
IMPORTANCE: Gene expression heterogeneity among isogenic bacteria is linked to clinically relevant scenarios, like biofilm formation and antibiotic tolerance. The recent development of bacterial single-cell RNA sequencing (scRNA-seq) enables the study of cell-to-cell variability in bacterial populations and the mechanisms underlying these phenomena. Here, we report a scRNA-seq workflow based on MATQ-seq with increased robustness, reduced cell loss, and improved transcript capture rate and gene coverage. Use of a more efficient reverse transcriptase and the integration of an rRNA depletion step, which can be adapted to other bacterial single-cell workflows, was instrumental for these improvements. Applying the protocol to the foodborne pathogen Salmonella, we confirmed transcriptional heterogeneity across and within different growth phases and demonstrated that our workflow captures small regulatory RNAs at a single-cell level. Due to low cell loss and high transcript capture rates, this protocol is uniquely suited for experimental settings in which the starting material is limited, such as infected tissues.
This compilation focuses on adolescent mental disorders and their prevention. It comprises three distinct studies, each contributing to a deeper understanding of this critical topic. This work addresses a critical gap in the understanding of, and approach to, adolescent mental health, and as a result reveals a critically important and urgently needed policy implication for action. The thematic structure of these studies begins with an examination of the epidemiology of child and adolescent mental disorders. Baseline data were collected from N = 877 adolescents with a mean age of 12.43 years (SD = 0.65). Mental health problems, such as depressive symptoms, non-suicidal self-injury, suicidal ideation, symptoms of eating disorders, and gender differences, are thoroughly examined. Results revealed a significant portion of our sample displaying mental health problems as early as the 6th and 7th grades, with girls generally being more affected than boys. The findings underscore the importance of early adolescence in the emergence of mental health problems and thereby emphasize the need for preventive measures. Moving beyond prevalence estimates, the compilation delves into the etiology of these disorders, exploring their potential correlation with a COVID-19 infection. Understanding the early signs and risk factors is crucial for timely support. While numerous studies have investigated potential risk and protective factors during the pandemic, our focus shifts to adolescents’ coping when an infection with the virus was involved (N = 2,154, M = 12.31, SD = 0.67). We hypothesized that students infected or with close family members infected, would exhibit an increased psychopathology and a decreased functioning of protective factors such as self-efficacy or self-esteem. We found no connection between infection and the mental health status within our sample, but protective factors and mental well-being were positively associated. Thus, universal primary prevention appears to be the preferred approach for promoting mental health. Lastly, the compilation introduces LessStress, a noteworthy contribution to more evidence-based prevention programs. This universal approach is designed to reduce stress in schools, accompanied by a cluster-randomized trial to evaluate its effectiveness (estimated sample size N = 1,894). Existing studies have demonstrated the effectiveness of stress prevention, leading us to introduce a short and easy-to-implement prevention program. There is positive evidence for one-lesson interventions in schools for promoting well-being and health behaviors among adolescents. LessStress is designed based on a life skills approach that not only imparts psychoeducational content but also teaches skills relevant to everyday life and directly applicable. Throughout these studies, a common thread emerges: the pressing need to address mental disorders during childhood and adolescence. These formative years play a pivotal role in the development of mental health problems. These formative years play a crucial role in the development of mental health problems. They highlight the importance of epidemiological data collection and analysis based on the latest models to develop prevention interventions that are not only effective but also reach young people on a global level.
Die Erforschung viraler Proteine ist wichtig, um virale Infektionen besser verstehen und
damit therapieren zu können. Die Aufklärung der DUB-Funktion auf dem viralen
Herpesprotein pUL36 ermöglicht ein besseres Verständnis des Infektionshergangs und
könnte zur Entwicklung eines Enzyminhibitors führen, der nur an diesem Enzym ansetzt,
nachdem es sich von den zellulären DUBs unterscheidet (Kattenhorn et al., 2005). In
dieser Arbeit konnten die vorherigen Daten, die eine stärkere Hemmung der DUB-
Mutante unter Interferoneinfluss zeigten, in unterschiedlichen Assay-Designs bestätigt
werden. Auch Versuche mit einem anderen Herpes simplex Virus Strang, bestätigten die
vorherigen Daten. Die Ergebnisse zeigen, dass die DUB-Funktion für HSV-1 wichtig ist für
die virale Evasion der zellulären Immunantwort. Die genaue Funktion der DUB in der
Infektion ist jedoch unklar. Aufgrund der vorbestehenden Datenlage erschien am
wahrscheinlichsten, dass die DUB-Funktion vor Eindringen des Herpes Simplex Virus in
den Zellkern zum Tragen kommt, womit es nach Abnahme des Interferons nicht zu einer
viralen Reaktivierung käme. Deshalb wurden Untersuchungen unternommen, um eine
mögliche Reaktivierung nach Abnahme des Interferons näher zu untersuchen. Hierfür
wurden zwei verschiedene Experimente entwickelt. Einmal wurde das Interferon direkt
nach Infektion und einmal 3 Tage nach Infektion (3dpi) abgenommen. Die Ergebnisse
zeigten beide eine stärkere Hemmung der DUB-HSV-1-Mutante unter Interferoneinfluss.
Bei Abnahme des Interferons direkt nach Infektion lag bei Wildtyp und Mutante ein
leichter Anstieg der Plaquezahlen vor, wobei dieser Effekt von der Dosis des Interferons
abhängig war. Eine hohe Interferondosis begünstigte bei beiden eine stärkere Hemmung,
allerdings bei beiden auch eine leichte Erhöhung der Plaquezahl nach Abnahme. Bei
einer niedrigen Dosis konnte nur eine stärkere Hemmung der DUB-Mutante, jedoch
keine Reaktivierung bei Wildtyp und Mutante nach Abnahme des Interferons gezeigt
werden. Bei Abnahme drei Tage nach Infektion zeigte sich sowohl bei dem Wildtyp-Virus
als auch der DUB- Mutante kein Anstieg in den Plaquezahlen. Es sind, nachdem
Deubiquitinierung nicht nur eine Rolle in der Verhinderung des proteosomalen Abbaus
von in die Zelle eingedrungenem Virus spielt, sondern auch der Zellregulation, mehrere
Szenarien denkbar, die diesen Phänotyp erklären könnten. Die DUB-Funktion könnte
zwar den proteosomalen Abbau durch Deubiqutinierung und damit Verhinderung der
Markierung des Virus zum zellulären Abbau verhindern. Allerdings könnten sich durch
einen langsameren Transport aus der Zelle oder in den Nucleus auch weniger Plaques
bei der Mutante als wie beim Wildtyp unter Interferoneinfluss bilden, nachdem das Virus
dann leichter Ziel antiviraler Proteine werden könnte. Oder die DUB-Funktion spielt eine
Rolle beim Eintritt in den Kern durch Modifikationen anderer Proteine. Virengenome
könnten auch durch eine fehlende DUB-Funktion reprimiert werden oder die Zelle durch
Apoptose absterben. Interessanterweise konnte keine Hemmung der DUB-Mutante in
Interferon behandelten U-2 OS Zellen gezeigt werden, von denen ein Defekt im STING-
vermittelten Signalweg bekannt ist. Vielleicht zeigt dies, dass das STING-Protein an dem
gezeigten DUB-Phänotyp beteiligt ist. Nachgewiesen ist außerdem bereits eine Funktion
des Enzyms bei der zweiten Umhüllung der Kapside bei Pseudorabiesvirus (Möhl, 2011).
Weitere Untersuchungen unter Einsatz bspw. von Immunfluoreszenz,
Proteasominhibitoren oder weiteren Zelllinien wie Saos-2, sind nötig, um die genaue
Funktion zu klären.
Die vier Crz-Neurone des ventralen Nervensystems von Drosophila melanogaster sammeln Evidenz, wann im Rahmen eines Paarungsakts zirka 6 Minuten vergangen sind. Diese Entscheidung ist für die männliche Fliege von Bedeutung, da das Männchen vor Ablauf dieser ~6 Minuten, welche den Zeitpunkt der Ejakulation darstellen, eher das eigene Leben opfern würde, als dass es die Paarung beenden würde. Nach Ablauf der ~6 Minuten fällt die Motivation des Männchens dagegen dramatisch ab. Im Rahmen der vorliegenden Arbeit wurde zunächst mittels optogenetischer neuronaler Inhibitionsprotokolle sowie Verhaltensanalysen das Phänomen der Evidenz-akkumulation in den Crz-Neuronen genauer charakterisiert. Dabei zeigte sich, dass die akkumulierte Evidenz auch während einer elektrischen Inhibition der Crz-Neurone persistierte. Dieses Ergebnis warf die Hypothese auf, dass das Äquivalent der akkumulierten Evidenz in den Crz-Neuronen biochemischer Natur sein könnte. Es wurde daraufhin ein Hochdurchsatzscreening-Verfahren entwickelt, mittels dessen 1388 genetische Manipulationen der Crz-Neurone durchgeführt und auf eine Änderung der Evidenzakkumulation getestet wurden. Nur ~30 genetische Manipulationen zeigten eine veränderte Evidenzakkumulation, wobei die meisten dieser Manipulationen den cAMP-Signalweg betrafen. Mittels der optogenetischen Photoadenylatzyklase bPAC, einer Reihe weiterer genetischer Manipulationen des cAMP-Signalwegs sowie der ex vivo Kalzium-Bildgebung und Fluoreszenzlebensdauer-Mikroskopie konnte bestätigt werden, dass cAMP das Äquivalent der in den Crz-Neuronen spannungsabhängig akkumulierten Evidenz darstellt, wobei die Kombination dieser Methoden nahelegte, dass der Schwellenwert der Evidenzakkumulation durch die cAMP-Bindungsaffinität der regulatorischen PKA-Untereinheiten festgelegt sein könnte. Mittels genetischer Mosaikexperimente sowie bildgebenden Verfahren konnte darüber hinaus gezeigt werden, dass innerhalb des Crz-Netzwerks eine positive Rückkopplungsschleife aus rekurrenter Aktivität sowie der cAMP-Akkumulation besteht, welche, sobald die cAMP-Spiegel den Schwellenwert erreichen, zu einem netzwerkweit synchronisierten massiven Kalziumeinstrom führt, was die Abgabe des Crz-Signals an nachgeschaltete Netzwerke triggert. Dieses Phänomen könnte ein Analogon des Aktionspotenzials auf Netzwerkebene sowie auf Intervallzeitskalen darstellen und wurde als „Eruption“ bezeichnet. Genetische, optogenetische sowie Bildgebungsexperimente konnten zeigen, dass die CaMKII derartige Eruptionen durch Niedrighalten der cAMP-Spiegel unterdrückt, was den Zeitmessmechanismus des ersten beschriebenen Intervallzeitmessers CaMKII offenlegt.
Aufgrund der Beeinträchtigung eines oder beider Beine sind viele Menschen zur selbstständigen Fortbewegung im Alltag auf ein Hilfsmittel angewiesen. Gehstützen sind das aufgrund hoher Nutzerfreundlichkeit am häufigsten eingesetzte Hilfsmittel bei kurz oder langandauernder Funktionseinschränkung.
Die im Vergleich zum normalen Gang erhöhte Belastung der oberen Extremitäten kann in schwerwiegenden Komplikationen wie Thrombosen, Gewebe- und Nervenschäden resultieren. Um diese möglichst gering zu halten, wurden im Laufe der Zeit verschiedene Gehstützenmodelle entwickelt.
Ziel der durchgeführten Studie war es, die Belastung der Hände bei verschiedenen hier zu Lande häufig genutzten Gehstützenmodellen und verschiedenen Entlastungen zu erfassen und diese miteinander zu vergleichen. Hierfür zogen wir 26 gesunde Probanden heran, die mit ergonomischen UAG, Arthritis-Gehstützen und anatomischen UAG eine definierte Strecke in festgesetzter, für alle gleicher Reihenfolge liefen. Die zwischen der Hand und dem Gehstützengriff angebrachten Sensormatten erfassten im ersten Studienteil die auf die komplette Hand einwirkende Last und im zweiten Studienteil die Belastung der radialen und ulnaren Hohlhandhälfte separat. Sensorsohlen erfassten zeitgleich die Bodenreaktionskraft.
Die Studie zeigte, dass die mit bis zu 70% des Körpergewichts (KG) beim Gehen mit UAG stark belastete Hand mit Arthritis-Gehstützen deutlich entlastet werden kann. Die Belastung konnte auf 16% verringert werden. Eine schwierigere Handhabe muss jedoch in Kauf genommen werden.
Bei Beschwerden der Hand, besonders im ulnaren Bereich, sollten anatomische UAG gegenüber ergonomischen UAG bevorzugt werden. Die Belastung der ulnaren Handfläche lag hiermit mit 17% des KG deutlich unter der Belastung mit ergonomischen UAG mit 23% des KG. Die Belastung der radialen Hälfte unterschied sich nicht.
Da die Belastung der Hand mit steigender Beinentlastung stieg, sollte die Entlastung möglichst gering und zeitlich kurzgehalten werden.
Arrhythmogene Kardiomyopathie (ACM) ist eine genetische Herzerkrankung, die durch Herzinsuffizienz, ventrikuläre Arrhythmien und plötzlichen Herztod gekennzeichnet ist. Mutationen in desmosomalen Proteinen der Zelladhäsion, wie Plakophilin 2 (PKP2) und Plakoglobin (PG), sind die häufigste Ursache der familiären ACM. Wie gestörte Zelladhäsion zum ACM-Phänotyp führt, ist jedoch nur teilweise geklärt. Potentielle Mechanismen sind eine gestörte Kalzium-(Ca2+)-Homöostase, mitochondrialer oxidativer Stress und metabolische Störungen. Ziel dieser Studie ist es, die mitochondriale Energetik und die Ca2+ -Homöostase in kardio-restriktiven PKP2-Knockout-Mäusen (KO) im Alter von 4, 8 und 12 Wochen sowie in PG-Knockout- Mäusen im Alter von 6 Wochen zu untersuchen. Vier Wochen alte PKP2-KO-Mäuse zeigten frühe Anzeichen von ACM, während alle anderen Altersgruppen typische Kennzeichen von ACM rekapitulierten. Kontraktilität, die damit verbundenen Ca2+ - Transienten, der Redoxstatus und das mitochondriale Membranpotenzial (ΔΨm) isolierter Kardiomyozyten wurden mit einem IonOptix-System bei elektrischer und β- adrenerger Stimulation untersucht. Alle desmosomalen KO-Kardiomyozyten zeigten eine verringerte diastolische Sarkomerlänge, was auf eine diastolische Dysfunktion hinwies. In allen PKP2 KO Kardiomyozyten lag außerdem ein erhöhter intrazellulärer Ca2+ -Spiegel vor, während in den PG KO-Kardiomyozyten das intrazellulärer Ca2+ unverändert war. PKP2 KO- und PG KO-Kardiomyozyten wiesen keine Ca2+ - Sensibilisierung der Myofilamente auf. Zur weiteren Bewertung der mitochondrialen Funktion wurde eine hochauflösende Respirometrie in isolierten Herzmitochondrien bei gleichzeitiger Überwachung von ΔΨm in PKP2 KO und PG KO Mäusen durchgeführt, welche in allen Versuchs- und Kontrollgruppen vergleichbar war. Im Verlauf der Versuche blieb der Redoxstatus stabil und es konnte kein Exzess reaktiver Sauerstoffspezies (ROS) festgestellt werden. Daraus konnte gefolgert werden, dass weder PKP2 KO noch PG KO-Mäuse eine beeinträchtigte mitochondriale Atmung aufwiesen. Diese Studie zeigt, dass isolierte PKP2 KO- oder PG KO-Kardiomyozyten EC-Kopplungsdefekte ohne mitochondriale Dysfunktion aufwiesen. Eine mitochondriale Dysfunktion konnte als treibender Faktor für die Progression des ACM- Phänotyps in den vorgestellten Mausmodellen ausgeschlossen werden. Weitere Studien sind erforderlich, um die mitochondriale Funktion im Zusammenhang mit ACM zu entschlüsseln.
Die COVID-19 Pandemie ist die bisher verheerendste Pandemie des 21. Jahrhunderts. Durch die Einführung neuer mRNA-basierter Impfstoffe sowie der hohen Rate natürlicher Infektionen konnte die weltweite SARS-CoV-2-Immunität gesteigert werden. Trotz aller Erfolge zur Eindämmung der Pandemie kann eine Infektion auch heute noch zu schweren Verläufen und Tod führen. Eine adäquate COVID-19-Therapie ist folglich auf potente Virostatika angewiesen. Eine durch Umgehung zeitaufwändiger klinischer Studien schnell verfügbare Alternative zu neu entwickelten Arzneimitteln ist die Anwendung etablierter Medikamente. Wir isolierten und charakterisierten ein von einem Patienten stammendes SARS-CoV-2-Virus. Dieses Virusisolat wurde bisher in elf Publikationen verwendet. Mittels quantitativer Echtzeit-Polymerasekettenreaktion untersuchten wir eine Substanzbibliothek mit mehr als 300 neuen und bereits zugelassenen Wirkstoffen auf ihre Wirksamkeit gegen SARS-CoV-2. Dabei konnten wir zeigen, dass der selektive Serotonin-Wiederaufnahmehemmer Fluoxetin die SARS-CoV-2-Replikation ab einer Dosis von 0,8 μg/ml signifikant inhibiert, einer bei der Behandlung von Depressionen häufig angewandten Dosierung. Der EC50-Wert lag bei 387 ng/ml. Die Behandlung mit Fluoxetin resultierte in einer reduzierten Zahl an Virusprotein-produzierenden Zellen, was darauf hindeutet, dass es die virale Reinfektion und/oder Proteinexpression inhibiert. Fluoxetin ist ein racemisches Gemisch, wobei das (S)-Enantiomer der potentere Serotonin-Wiederaufnahmehemmer ist. Wir konnten zeigen, dass beide Enantiomere einen vergleichbaren antiviralen Effekt gegen SARS-CoV-2 aufweisen, wodurch das (R)-Enantiomer bei virologischer Indikation gegebenenfalls präferiert werden sollte. Fluoxetin hat keinen Einfluss auf die Replikation des Tollwut-Virus und des Humanen Respiratorischen Synzytial-Virus, was auf eine Virusspezifität hindeutet. Weitere aus der Bibliothek stammende signifikante Inhibitoren der SARS-CoV-2-Replikation sind die am Institut für Organische Chemie Würzburg entwickelten Substanzen AKS 232 und AKS 128. Neben der medikamentösen Therapie ist die akkurate Bestimmung neutralisierender Antikörper gegen SARS-CoV-2 zur Quantifizierung des bestehenden (Re-) Infektionsschutzes sowie zur Planung zukünftiger Impfstrategien von großer Bedeutung. Im Rahmen dieser Arbeit entwickelten wir unter Verwendung der quantitativen Echtzeit-Polymerasekettenreaktion erfolgreich ein zuverlässiges Testverfahren zur Detektion neutralisierender anti-SARS-CoV-2 Antikörper.
Die ESWT ist eine nichtoperative Option, kann aber auch ergänzend zur operativen Therapie zur Behandlung von verzögerter (Knochen-)Heilung (VH) und Pseudarthrosen (PA) eingesetzt werden. Ihre Wertigkeit sowie beeinflussende Faktoren wurden an der oberen Extremität bisher nicht ausreichend quantifiziert. Sechzig Patienten wurden retrospektiv nach Anwendung einer ESWT hinsichtlich Ausheilungsrate und Konsolidierungszeit untersucht.
Bei 70 % der Patienten kam es zur Ausheilung. Das Durchschnittsalter der Geheilten und Nichtgeheilten unterschied sich nicht signifikant. Das Rauchverhalten und die Zeit zwischen Trauma/OP und ESWT war bei Geheilten und Nichtgeheilten ohne signifikanten Unterschied. Die Ausheilungsrate war am höchsten an Mittelhandknochen/Finger/Daumen (91 %), gefolgt von Unterarmschaft (88 %), Epi-/Metaphyse des Unterarms (67 %) und zuletzt Handwurzelknochen (59 %). Nach konservativer Vorbehandlung heilten 55 %, bei > 2 Voroperationen 67 %, ohne Vorbehandlung 73 % und nach 1 Voroperation 75 %. Die weitere Analyse hinsichtlich der operativen Vorversorgung ergab nach alleiniger ORIF 85 %, ohne Voroperation 64 % und nach ORIF mit Knochenanfrischung/-transplantation 57 % Heilungsrate. Bei intraoperativer ESWT kombiniert mit Knochendebridement/-transplantation + ORIF heilten 67 %, kombiniert mit einer alleinigen ORIF 86 %. Bei alleiniger ESWT oder mit nur minimalen Maßnahmen konsolidierten 70 %.
Die ESWT ist in jedem Stadium der Knochenheilungsstörung gleich wirksam. Die Prinzipien von Stabilität und Auffüllung bei vorhandenen Knochendefekten müssen auch bei der Anwendung der ESWT berücksichtigt werden, dann wirkt die ESWT alleinig oder kombiniert mit einer Operation gleichermaßen. Der negative Einfluss von Knochendefekten/-resorption ist auch mit ESWT noch nachweisbar. Ebenso ist die Behandlung des Kahnbeins problematischer als übrige Lokalisationen. Eine vorangegangene Operation stellt keinen negativen Faktor dar, auch wenn Fremdmaterial einliegt.
SPRED 2 wirkt inhibitorisch auf den Ras/ERK-MAPK-Signalweg. Im Knockout Mausmodell
zeigen sich einige schwerwiegende phänotypische Eigenschaften, unter anderem zeigen sich
ein genereller Minderwuchs, veränderte hormonelle Regelkreise, neurologische Auffälligkeiten,
eine deutlich verringerte Lebenserwartung, sowie kardiale Veränderungen. Besonders
schwerwiegende SPRED 2 KO typische Ausprägungen im Herzen sind hierbei eine myokardiale
Fibrosierung, eine myokardiale Hypertrophie und Herzrhythmusstörungen.
In dieser Arbeit wurden insbesondere kardiale Veränderungen auf Zell- und Proteinebene
untersucht. Zur Proteinanalyse der Kardiomyozyten wurden Western Blots und eine Schnittbildgebung
angefertigt. Für eine funktionelle Untersuchung wurden isolierte vitale Kardiomyozyten
mittels Fluoreszenzfarbstoffen untersucht und unter elektrischer Stimulation beobachtet.
Desweiteren wurden isolierte Mitochondrien auf ihren Stoffwechsel und eventuelle
Defekte hin analysiert. Hierbei konnte gezeigt werden, dass junge SPRED2 KO Mäuse keine
wesentlichen hämodynamischen Einschränkungen aufweisen und eine gute Kompensationsfähigkeit
gegenüber einer Nachlaststeigerung aufweisen. Auch gezeigt werden konnte, dass
Veränderungen im Rahmen der Zellkontraktion beim Kalziumhaushalt und Membranpotential
existieren und im Zusammenhang mit einer verminderten Expression von SERCA und CaV1.2
stehen. Bei der Untersuchung von Mitochondrien konnten keine wesentlichen Defizite der
mitochondrialen Funktion der SPRED 2 KO Mäuse gefunden werden. In diesem Zusammenhang
ist die bekannte Störung der Autophagie am ehesten Ursache für eine gesteigerte Fibrosierung,
sowie der gesteigerten Apoptose der Kardiomyozyten. In Folge dessen könnten die
oben beschriebenen Veränderungen des Kalziumhaushaltes der Kardiomyozyten stehen und
letztendlich über maligne Herzrhythmusstörungen zum vorzeitigen Versterben führen.
Pancreatic ductal adenocarcinoma (PDAC) is predominantly driven by mutations in KRAS and TP53. However, PDAC tumors display deregulated levels of MYC and are a paradigm example for MYC-driven and -addicted tumors. For many years MYC was described as a transcription factor that regulates a pleiotropic number of genes to drive proliferation. Recent work sheds a different light on MYC biology. First, changes in gene expression that come along with the activation of MYC are mild and MYC seems to act more as a factor that reduces stress and increases resilience towards challenges during transcription. Second, MYC is a strong driver of immune evasion in different entities. In this study we depleted MYC in murine PDAC cells and revealed the immune dependent regression of tumors in an orthotope transplant model, as well as the activation of the innate immune system using global expression analysis, immunoblotting and fCLIP.
These experiments revealed that endogenous double-stranded RNA is binding as a viral mimicry to Toll-like receptor 3, causing activation of TBK1 and downstream activation of a proimmunogenic transcription program. The regression of tumors upon depletion of MYC is dependent on this pathway since the knockout of TBK1 prevents regression of tumors after depletion of MYC.
We can summarize this study in three main findings: First, the dominant and most important function of MYC in tumors is not to drive proliferation but to promote immune evasion and prevent immune-dependent regression of tumors. Second, cells monitor defects or delay in splicing and RNA processing and activate the immune system to clear cells that face problems with co-transcriptional processing. Third, MYC suppresses the activation of the cell-intrinsic innate immune system and shields highly proliferating cells from the recognition by the immune system.
To translate this into a therapeutically approach, we replaced the shRNA mediated depletion of MYC by treatment with cardiac glycosides. Upon treatment with cardiac glycosides tumor cells reduce uptake of nutrients, causing a downregulation of MYC translation, inhibition of proliferation, glycolysis and lactate secretion. Lactate is a major reason for immune evasion in solid tumors since it dampens, amongst others, cytotoxic T cells and promotes regulatory T cells.
Treatment of mice with cardiac glycosides causes a complete and immune-dependent remission of PDAC tumors in vivo, pointing out that cardiac glycosides have strong proimmunogenic, anti-cancer effects. More detailed analyses will be needed to dissect the full mechanism how cardiac glycosides act on MYC translation and immune evasion in PDAC tumors.
Every year, stroke affects over 100 million people worldwide and the number of cases continues to grow. Ischemic stroke is the most prevalent form of stroke and rapid restoration of blood flow is the primary therapeutic aim. However, recanalization might fail or reperfusion itself induces detrimental processes leading to infarct progression. Previous studies identified platelets and immune cells as drivers of this so-called ischemia/reperfusion (I/R) injury, establishing the concept of ischemic stroke as thrombo-inflammatory disease. Reduced cerebral blood flow despite recanalization promoted the hypothesis that thrombus formation within the cerebral microcirculation induces further tissue damage. The results presented in this thesis refute this: using complementary methodologies, it was shown that infarct growth precedes the occurrence of thrombi excluding them as I/R injury-underlying cause. Blood brain barrier disruption is one of the hallmarks of ischemic stroke pathology and was confirmed as early event during reperfusion injury in the second part of this study. Abolished platelet α-granule release protects mice from vascular leakage in the early reperfusion phase resulting in smaller infarcts. Using in vitro assays, platelet α-granule-derived PDGF-AB was identified as one factor contributing to blood-brain barrier disruption.
In vivo visualization of platelet activation would provide important insights in the spatio-temporal context of platelet activation in stroke pathology. As platelet signaling results in elevated intracellular Ca2+ levels, this is an ideal readout. To overcome the limitations of chemical calcium indicators, a mouse line expressing an endogenous calcium reporter specifically in platelets and megakaryocytes was generated. Presence of the reporter did not interfere with platelet function, consequently these mice were characterized in in vivo and ex vivo models.
Upon ischemic stroke, neutrophils are among the first cells that are recruited to the brain. Since for neutrophils both, beneficial and detrimental effects are described, their role was investigated within this thesis. Neither neutrophil depletion nor absence of NADPH-dependent ROS production (Ncf-/- mice) affected stroke outcome. In contrast, abolished NET-formation in Pad4-/- mice resulted in reduced infarct sizes, revealing detrimental effects of NETosis in the context of ischemic stroke, which might become a potential therapeutic target.
Cerebral venous (sinus) thrombosis, CV(S)T is a rare type of stroke with mainly idiopathic onset. Whereas for arterial thrombosis a critical contribution of platelets is known and widely accepted, for venous thrombosis this is less clear but considered more and more. In the last part of this thesis, it was shown that fab-fragments of the anti-CLEC-2 antibody INU1 trigger pathological platelet activation in vivo, resulting in foudroyant CVT accompanied by heavy neurological symptoms. Using this novel animal model for CVT, cooperative signaling of the two platelet receptors CLEC-2 and GPIIb/IIIa was revealed as major trigger of CVT and potential target for treatment.
The mammalian central clock, located in the suprachiasmatic nucleus (SCN) of the anterior hypothalamus, controls circadian rhythms in behaviour such as the sleep-wake cycle. It is made up of approximately 20,000 heterogeneous neurons that can be classified by their expression of neuropeptides. There are three major populations: AVP neurons (arginine vasopressin), VIP neurons (vasoactive intestinal peptide), and GRP neurons (gastrin releasing peptide). How these neuronal clusters form functional units to govern various aspects of rhythmic behavior is poorly understood. At a molecular level, biological clocks are represented by transcriptional-posttranslational feedback loops that induce circadian oscillations in the electrical activity of the SCN and hence correlate with behavioral circadian rhythms. In mammals, the sleep wake cycle can be accurately predicted by measuring electrical muscle and brain activity. To investigate the link between the electrical activity of heterogeneous neurons of the SCN and the sleep wake cycle, we optogenetically manipulated AVP neurons in vivo with SSFO (stabilized step function opsin) and simultaneously recorded an electroencephalogram (EEG) and electromyogram (EMG) in freely moving mice. SSFO-mediated stimulation of AVP positive neurons in the anterior hypothalamus increased the total amount of wakefulness during the hour of stimulation. Interestingly, this effect led to a rebound in sleep in the hour after stimulation. Markov chain sleep-stage transition analysis showed that the depolarization of AVP neurons through SSFO promotes the transition from all states to wakefulness. After the end of stimulation, a compensatory increase in transitions to NREM sleep was observed. Ex vivo, SSFO activation in AVP neurons causes depolarization and modifies the activity of AVP neurons. Therefore, the results of this thesis project suggest an essential role of AVP neurons as mediators between circadian rhythmicity and sleep-wake behaviour.